Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
US10647739B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10647739-B2 |
| Application number | US-201515128673-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 24, 2015 |
| Priority date | Mar 24, 2014 |
| Publication date | May 12, 2020 |
| Grant date | May 12, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention relates to a method for producing derivatives of O-α-glucosylated flavonoid, comprising at least one step of incubating a glucansucrase with a flavonoid and at least one sucrose, the flavonoid being a flavonoid which is monohydroxylated or hydroxylated in a non-vicinal manner on the B cycle. The invention also relates to novel O-α-glucosylated flavonoid derivatives, and to the use thereof.
Opening claim text (preview).
The invention claimed is: 1. A process for producing O-α-glucosylated flavonoid derivatives, comprising at least one step of incubating a glucansucrase with a flavonoid and at least one sucrose, wherein: (A) said flavonoid comprises formula (I) below: wherein the C ring represents a ring chosen from the group consisting of the rings of formula (II) and formula (IV) below: wherein: the R 1 group represents a B ring of formula (VI) below: wherein: (a) just one of the groups chosen from R 8 , R 9 , R 10 , R 11 and R 12 represents a hydroxyl group, the other groups among R 8 , R 9 , R 10 , R 11 and R 12 , which may be identical or different, being chosen from the group consisting of a hydrogen atom; a C 1 alkoxy group; a —C(W) group; and an —O(W) group, wherein W represents a chain consisting of 1 to 6 glycoside(s); or (b) R 8 and just one of the groups chosen from R 10 , R 11 and R 12 represents a hydroxyl group, R 9 and the other groups among R 10 , R 11 and R 12 , which may be identical or different being chosen from the group consisting of a hydrogen atom; a C 1 alkoxy group; a —C(W) group; and an —O(W) group, wherein W represents a chain consisting of 1 to 6 glycoside(s); the R 2 and R 3 groups, which may be identical or different, being chosen from the group consisting of a hydrogen atom and an —OH group; R 1 ′, R 2 ′ and R 3 ′ is a hydrogen atom or R 3 and R 3 ′ groups together form an ═O group; R 4 , R 5 , R 6 and R 7 , which may be identical or different, being chosen from the group consisting of a hydrogen atom; a C 1 alkoxy group; an —OH; a —C(W) group; and an —O(W) group, wherein W represents a chain consisting of 1 to 6 glycoside(s); and (B) said glucansucrase comprises an amino acid sequence having at least 95% identity with the amino acid sequence of SEQ ID NO: 11. 2. The process in of claim 1 , wherein R 10 represents a hydroxyl group, the other groups among R 8 , R 9 , R 11 and R 12 , which may be identical or different, being chosen from the group consisting of a hydrogen atom; a C 1 alkoxy group; a —C(W) group; and an —O(W) group, wherein W represents a chain consisting of 1 to 6 glycoside(s). 3. The process of claim 2 , wherein R 10 represents a hydroxyl group and R 8 , R 9 , R 11 and R 12 represent hydrogen atoms. 4. The process of claim 1 , wherein R 8 and just one of the groups chosen from R 10 , R 11 and R 12 represent a hydroxyl group, R 9 and the other groups among R 10 , R 11 and R 12 , which may be identical or different, being chosen from the group consisting of a hydrogen atom; a C 1 alkoxy group; a —C(W) group; and an —O(W) group, wherein W represents a chain consisting of 1 to 6 glycoside(s). 5. The process of claim 4 , wherein R 10 represents a hydroxyl group and R 9 , R 11 and R 12 represent hydrogen atoms. 6. The process of claim 1 , wherein R 1 ′ and R 2 ′ represent hydrogen atoms, R 2 represents a hydrogen atom or an —OH group, and R 3 and R 3 ′ together form an ═O group. 7. The process of claim 1 , wherein two of the R 4 , R 5 , R 6 and R 7 groups represent a hydroxyl group, the other two groups are as defined in claim 1 . 8. The process of claim 7 , wherein R 5 and R 7 represent hydrogen atoms. 9. The process of claim 1 , wherein said flavonoid is of formula (VII), (VII) or (IX) below: 10. The process of claim 1 , wherein said glucansucrase comprises an amino acid sequence having at least 98% identity with the amino acid sequence of SEQ ID NO: 11. 11. The process of claim 1 , wherein said glucansucrase comprises an amino acid sequence having at least 99% identity with the amino acid sequence of SEQ ID NO: 11. 12. The process of claim 1 , wherein said glucansucrase comprises the amino acid sequence of SEQ ID NO: 11.
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
Processes for the preparation of sugar derivatives · CPC title
having an oxygen atom of the saccharide radical bound to a cyclohexyl radical, e.g. kasugamycin · CPC title
Glycosides, e.g. rutin · CPC title
Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.